21.10
price up icon1.01%   0.21
after-market Handel nachbörslich: 21.10
loading
Schlusskurs vom Vortag:
$20.89
Offen:
$20.245
24-Stunden-Volumen:
949.00K
Relative Volume:
3.63
Marktkapitalisierung:
$838.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.05M
KGV:
-8.0436
EPS:
-2.6232
Netto-Cashflow:
$-68.97M
1W Leistung:
-7.46%
1M Leistung:
-4.09%
6M Leistung:
-23.19%
1J Leistung:
+14.61%
1-Tages-Spanne:
Value
$20.00
$21.89
1-Wochen-Bereich:
Value
$20.00
$23.26
52-Wochen-Spanne:
Value
$15.47
$36.37

Arrivent Biopharma Inc Stock (AVBP) Company Profile

Name
Firmenname
Arrivent Biopharma Inc
Name
Telefon
240-780-6356
Name
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Name
Mitarbeiter
52
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
AVBP's Discussions on Twitter

Vergleichen Sie AVBP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AVBP
Arrivent Biopharma Inc
21.10 838.21M 0 -81.05M -68.97M -2.6232
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-20 Eingeleitet B. Riley Securities Buy
2025-03-10 Eingeleitet Guggenheim Buy
2024-07-22 Eingeleitet Oppenheimer Outperform
2024-04-30 Eingeleitet H.C. Wainwright Buy
2024-02-20 Eingeleitet Citigroup Buy
2024-02-20 Eingeleitet Goldman Buy
2024-02-20 Eingeleitet Jefferies Buy
Alle ansehen

Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten

pulisher
Jun 13, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases New Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by California State Teachers Retirement System - Defense World

Jun 12, 2025
pulisher
Jun 07, 2025

Where are the Opportunities in (AVBP) - news.stocktradersdaily.com

Jun 07, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Raises Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Reduces Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Comparing Immutep (NASDAQ:IMMP) and ArriVent BioPharma (NASDAQ:AVBP) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Rating of “Buy” by Analysts - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MyChesCo

Jun 02, 2025
pulisher
Jun 02, 2025

BNP Paribas Financial Markets Decreases Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,327 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 30, 2025
pulisher
May 29, 2025

Promising Outlook for ArriVent BioPharma: Buy Rating Justified by Upcoming EGFR PACC Mutant NSCLC Program Updates - TipRanks

May 29, 2025
pulisher
May 29, 2025

Deutsche Bank AG Boosts Stock Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 29, 2025
pulisher
May 25, 2025

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 4.5% – Here’s What Happened - Defense World

May 25, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Atea Pharmaceuticals (NASDAQ:AVIR) to “Hold” - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Downgrades ArriVent BioPharma (NASDAQ:AVBP) to Strong Sell - Defense World

May 24, 2025
pulisher
May 22, 2025

ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Jones Trading - Defense World

May 22, 2025
pulisher
May 20, 2025

JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ArriVent BioPharma (AVBP) Coverage Initiated with 'Buy' Rating | - GuruFocus

May 20, 2025
pulisher
May 20, 2025

JonesResearch Begins Coverage on ArriVent Biopharma (AVBP) with Optimistic Outlook | AVBP Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Purchases 10,498 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Boosts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World

May 20, 2025
pulisher
May 18, 2025

ArriVent BioPharma Reports Q1 2025 Financial Results and Highlights Key Achievements - MSN

May 18, 2025
pulisher
May 18, 2025

Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo

May 18, 2025
pulisher
May 17, 2025

When the Price of (AVBP) Talks, People Listen - news.stocktradersdaily.com

May 17, 2025
pulisher
May 17, 2025

Q2 EPS Estimates for ArriVent BioPharma Cut by HC Wainwright - Defense World

May 17, 2025
pulisher
May 17, 2025

ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $40.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Has $293,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 16, 2025
pulisher
May 16, 2025

B. Riley Lifts Earnings Estimates for ArriVent BioPharma - Defense World

May 16, 2025
pulisher
May 15, 2025

Synnovation Therapeutics Welcomes Rafael G. Amado, M.D., to Board of Directors - MyChesCo

May 15, 2025
pulisher
May 14, 2025

ArriVent BioPharma (AVBP) Receives Price Target Increase by HC W - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Is ArriVent BioPharma (NASDAQ:AVBP) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AV - GuruFocus

May 14, 2025
pulisher
May 14, 2025

ArriVent Biopharma (AVBP) Price Target Increased by Analyst | AVBP Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Voya Investment Management LLC Acquires Shares of 8,373 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 14, 2025
pulisher
May 14, 2025

Tower Research Capital LLC TRC Has $43,000 Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 14, 2025
pulisher
May 12, 2025

ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

ArriVent Biopharma (AVBP) Projects Financial Stability Through 2 - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ArriVent Biopharma (AVBP) Projects Financial Stability Through 2026 | AVBP Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ArriVent (AVBP) Advances Oncology Pipeline with Key Milestones Ahead | AVBP Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ArriVent BioPharma Reports First Quarter 2025 Financial Results - The Manila Times

May 12, 2025
pulisher
May 12, 2025

ArriVent BioPharma (AVBP) Expected to Announce Earnings on Wednesday - Defense World

May 12, 2025
pulisher
May 06, 2025

How to Take Advantage of moves in (AVBP) - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Arrivent Biopharma Inc expected to post a loss of 66 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 05, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Wells Fargo & Company MN - Defense World

May 05, 2025
pulisher
May 04, 2025

ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down – Here’s Why - Defense World

May 04, 2025
pulisher
May 04, 2025

Barclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 04, 2025
pulisher
May 04, 2025

Invesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 04, 2025
pulisher
May 02, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by JPMorgan Chase & Co. - Defense World

May 02, 2025
pulisher
May 01, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - Defense World

May 01, 2025
pulisher
May 01, 2025

Legal & General Group Plc Purchases 10,783 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

May 01, 2025

Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):